Afatinib and Erlotinib in the treatment of squamous-cell lung cancer

M. Tagliamento, C. Genova, E. Rijavec, G. Rossi, F. Biello, M.G. Dal Bello, A. Alama, S. Coco, S. Boccardo, F. Grossi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2055-2062
Number of pages8
JournalExpert Opinion on Pharmacotherapy
Volume19
Issue number18
DOIs
Publication statusPublished - 2018

Keywords

  • afatinib
  • EGFR
  • erlotinib
  • Squamous-cell lung cancer
  • tyrosine kinase inhibitors

Cite this